Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1980 2
1981 1
1983 1
1985 2
1987 2
1988 1
1989 11
1990 5
1991 9
1992 7
1993 14
1994 6
1995 15
1996 14
1997 15
1998 18
1999 6
2000 6
2001 6
2002 10
2003 12
2004 8
2005 5
2006 11
2007 10
2008 5
2009 8
2010 9
2011 12
2012 10
2013 16
2014 18
2015 16
2016 9
2017 11
2018 16
2019 7
2020 8
2021 6
2022 8
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials.
Yan R, Cai H, Cui Y, Su D, Cai G, Lin F, Feng T. Yan R, et al. Eur J Neurol. 2023 Apr;30(4):1118-1134. doi: 10.1111/ene.15651. Epub 2022 Dec 11. Eur J Neurol. 2023. PMID: 36437702 Review.
METHOD: Randomized controlled trials enrolling PD patients treated with selegiline, rasagiline, safinamide or zonisamide as adjuvant therapy to levodopa were identified. ...The surface under the cumulative ranking results showed that safinamide 100 mg …
METHOD: Randomized controlled trials enrolling PD patients treated with selegiline, rasagiline, safinamide or zonisamid …
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis.
Binde CD, Tvete IF, Gåsemyr JI, Natvig B, Klemp M. Binde CD, et al. Eur J Clin Pharmacol. 2020 Dec;76(12):1731-1743. doi: 10.1007/s00228-020-02961-6. Epub 2020 Jul 24. Eur J Clin Pharmacol. 2020. PMID: 32710141 Free PMC article.
METHODS: We performed a systematic literature search identifying randomized controlled trials investigating 4 dopamine agonists (cabergoline, pramipexole, ropinirole, rotigotine) and 3 MAO-B inhibitors (selegiline, rasagiline, safinamide) for Parkinson's dise …
METHODS: We performed a systematic literature search identifying randomized controlled trials investigating 4 dopamine agonists (cabergoline …
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O'Brien JT. Stinton C, et al. Am J Psychiatry. 2015 Aug 1;172(8):731-42. doi: 10.1176/appi.ajp.2015.14121582. Epub 2015 Jun 18. Am J Psychiatry. 2015. PMID: 26085043 Free article. Review.
Descriptive summaries provide some evidence of benefits for galantamine, modafinil, levodopa, rotigotine, clozapine, duloxetine, clonazepam, ramelteon, gabapentin, zonisamide, and yokukansan. Piracetam, amantadine, selegiline, olanzapine, quetiapine, risperidone, and cital …
Descriptive summaries provide some evidence of benefits for galantamine, modafinil, levodopa, rotigotine, clozapine, duloxetine, clonazepam, …
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
Deng X, Shang X, Guo K, Zhou L, Wang Y, Wu Y, Liang S, E F, Liu W, Wang Z, Li X, Yang K. Deng X, et al. Addict Biol. 2023 Aug;28(8):e13303. doi: 10.1111/adb.13303. Addict Biol. 2023. PMID: 37500482 Review.
The network meta-analysis showed that compared with placebo, varenicline + bupropion (OR = 3.53, 95% CI [2.34, 5.34]), selegiline + nicotine replacement therapy (NRT) (OR = 3.78, 95% CI [1.20, 11.92]), nortriptyline + NRT (OR = 2.33, 95% CI [1.21, 4.47), nortriptyline (OR …
The network meta-analysis showed that compared with placebo, varenicline + bupropion (OR = 3.53, 95% CI [2.34, 5.34]), selegiline + n …
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.
Maski K, Trotti LM, Kotagal S, Robert Auger R, Swick TJ, Rowley JA, Hashmi SD, Watson NF. Maski K, et al. J Clin Sleep Med. 2021 Sep 1;17(9):1895-1945. doi: 10.5664/jcsm.9326. J Clin Sleep Med. 2021. PMID: 34743790 Free PMC article.
Evidence for the following interventions is presented: armodafinil, clarithromycin, clomipramine, dextroamphetamine, flumazenil, intravenous immune globulin (IVIG), light therapy, lithium, l-carnitine, liraglutide, methylphenidate, methylprednisolone, modafinil, naps, pitolisant, …
Evidence for the following interventions is presented: armodafinil, clarithromycin, clomipramine, dextroamphetamine, flumazenil, intravenous …
Antioxidant treatments for schizophrenia.
Magalhães PV, Dean O, Andreazza AC, Berk M, Kapczinski F. Magalhães PV, et al. Cochrane Database Syst Rev. 2016 Feb 5;2(2):CD008919. doi: 10.1002/14651858.CD008919.pub2. Cochrane Database Syst Rev. 2016. PMID: 26848926 Free PMC article. Review.
MAIN RESULTS: The review includes 22 RCTs of varying quality and sample size studying Ginkgo biloba, N-acetyl cysteine (NAC), allopurinol, dehydroepiandrosterone (DHEA), vitamin C, vitamin E or selegiline. Median follow-up was eight weeks. Only three studies including a mi …
MAIN RESULTS: The review includes 22 RCTs of varying quality and sample size studying Ginkgo biloba, N-acetyl cysteine (NAC), allopurinol, d …
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations.
Rossano F, Caiazza C, Sobrino A, Solini N, Vellucci A, Zotti N, Fornaro M, Gillman K, Cattaneo CI, Van den Eynde V, Birkenhager TK, Ruhé HG, Stahl S, Iasevoli F, de Bartolomeis A. Rossano F, et al. Eur Neuropsychopharmacol. 2023 Jul;72:60-78. doi: 10.1016/j.euroneuro.2023.03.012. Epub 2023 Apr 21. Eur Neuropsychopharmacol. 2023. PMID: 37087864
The present systematic review and meta-analysis appraises the evidence of different formulations/dosages of selegiline across different psychiatric conditions. We inquired PubMed/MEDLINE/Cochrane-Central/WHO-ICTRP/Clarivate-WebOfScience and the Chinese-Electronic-Journal D …
The present systematic review and meta-analysis appraises the evidence of different formulations/dosages of selegiline across differe …
Efficacy of rasagiline for the treatment of Parkinson's disease: an updated meta-analysis.
Chang Y, Wang LB, Li D, Lei K, Liu SY. Chang Y, et al. Ann Med. 2017 Aug;49(5):421-434. doi: 10.1080/07853890.2017.1293285. Epub 2017 Mar 15. Ann Med. 2017. PMID: 28293967 Review.
OBJECTIVE: Rasagiline is a second-generation potent selective inhibitor of monoamine oxidase-B. ...CONCLUSIONS: Our results confirm the efficacy of rasagiline in PD. Further studies are required to establish the optimal dose of rasagiline, as well as to deter …
OBJECTIVE: Rasagiline is a second-generation potent selective inhibitor of monoamine oxidase-B. ...CONCLUSIONS: Our results confirm t …
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Rao Y, Yang R, Zhao J, Cao Q. Rao Y, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Aug 1;51(4):480-490. doi: 10.3724/zdxbyxb-2022-0145. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 37202104 Free PMC article. English.
There are 13 antidepressants used in total, including amitriptyline, vilazodone, fluoxetine, selegiline, paroxetine, imipramine, desipramine, sertraline, nortriptyline, escitalopram, citalopram, venlafaxine and duloxetine. ...There are 13 antidepressants used in total, inc …
There are 13 antidepressants used in total, including amitriptyline, vilazodone, fluoxetine, selegiline, paroxetine, imipramine, desi …
Antidepressants for smoking cessation.
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Hughes JR, et al. Cochrane Database Syst Rev. 2014 Jan 8;2014(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Cochrane Database Syst Rev. 2014. PMID: 24402784 Free PMC article. Updated. Review.
The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methionine (SAMe); selegiline; sertraline; St. John's wort; tryptophan; venlafaxine; and zimeledine. ...Significant effects were also not de …
The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methion …
340 results